Crystalys Doses First Patients in Europe for Phase...
Category : Clinical Trial Update 3 February 2026Crystalys Therapeutics has announced that the first patients have been dosed at European clinical si...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Mwyngil Therapeutics Initiates Phase 1 Study of BT...
Category : Clinical Trial Update 3 February 2026Mwyngil Therapeutics has announced the initiation of a Phase 1 clinical study of BT-409. BT-409 is a...
Japan Leads Asia in FDA Novel Drug Approvals
Category : Approval/Launch 3 February 2026Japan has emerged as Asia’s top performer in FDA novel-drug approvals. Between 2015 and 2023,...
AstraZeneca Signs $18.5 Billion Licensing Deal Wit...
Category : Licensing/Collaboration Deal 3 February 2026AstraZeneca has entered a landmark licensing agreement with China’s CSPC Pharmaceutical Group....
ENA Respiratory doses first participants in phase...
Category : Clinical Trial Update 2 February 2026"ENA Respiratory, a clinical-stage pharmaceutical company developing antiviral host defence enh...
Latest Newsletter Post
-
AstraZeneca Signs $18.5 Billion Lic..
3 February 2026
-
Japan Leads Asia in FDA Novel Drug..
3 February 2026
-
Mwyngil Therapeutics Initiates Phas..
3 February 2026
-
Crystalys Doses First Patients in E..
3 February 2026
-
Almirall’s Seysara receives China N..
2 February 2026
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com